1. International Drug Monitoring: The Role of National Centres. World Health Organization Technical Report Series, No. 498, Geneva, 1972.
2. W.H.W. Inman, and E.P. Gill, eds., Monitoring for Drug Safety, Second Edition, 107–118, MTP Press, Lancaster (1986).
3. J. McEwen, and B. Vrhovac, Panel on management of ADR reports in selected national centers, Drug Information J. 19:329–44 (1985).
4. J.P. Griffin, and J.C.P. Weber, Voluntary systems of adverse reaction reporting, in: “Medicines: Regulation, Research and Risk,” J.P. Griffin, P.F. D’Arcy, D.W.G. Harron, eds., Greystone Books Ltd., Antrim (1989).
5. N. Moore, G. Paux, B. Begaud, M. Biour, E. Loupi, F. Boismare, and R.J. Royer, Adverse drug reactions monitoring: doing it the French way, Lancet. 2:1056–8 (1985).